The aim of this study was to evaluate the role of RBMS 3 in the EMT process in invasive ductal carcinoma (IDC) patient-derived tumors and also in functional in vitro models of HER-2-enriched and TNBC cancer cell lines. This evidence concerns the gene ERBB2 and cancer.